|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9700 HKD | -4.90% |
|
-2.02% | +21.25% |
| 06-26 | Fusen Pharma Gets Marketing Nod for Influenza Drug in China | MT |
| 06-18 | Fusen Pharma Unit to Raise 300 Million Yuan From State-Owned Investors | MT |
| Market Cap | 622M 717M 91.45M 80.18M 73.91M 69.19M 130M 8.63B 132M 888M 344M 4.26B 343M 336M 14.78B | P/E 2024 |
-2.95x | P/E 2025 | -45.1x |
|---|---|---|---|---|---|
| Enterprise Value | 844M 973M 124M 109M 100M 93.89M 176M 11.7B 180M 1.21B 466M 5.78B 466M 456M 20.06B | EV / Sales 2024 |
2.83x | EV / Sales 2025 | 2.76x |
| Free-Float |
26.11% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -4.90% | ||
| 1 week | -2.02% | ||
| Current month | -10.19% | ||
| 1 month | -11.01% | ||
| 3 months | -11.82% | ||
| 6 months | +21.25% | ||
| Current year | +21.25% |
| 1 week | 0.96 |  | 1.09 |
| 1 month | 0.91 | | 1.09 |
| Current year | 0.68 | | 1.44 |
| 1 year | 0.3 | | 1.75 |
| 3 years | 0.24 | | 1.75 |
| 5 years | 0.24 | | 3.48 |
| 10 years | 0.24 | | 20 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhen Li
DFI | Director of Finance/CFO | 48 | 2019-04-17 |
Zhi Ming Cao
IRC | Investor Relations Contact | 40 | 2013-01-17 |
Yuk Hong Yeung
SEC | Corporate Secretary | 36 | 2024-09-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Tai Sheng Hou
BRD | Director/Board Member | 63 | 2017-04-06 |
Yong Sheng Chi
BRD | Director/Board Member | 64 | 2017-04-06 |
Qing Fen Meng
BRD | Director/Board Member | 61 | 2017-04-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-04-18 | Other | Chairman | 650,000 | 0.0867% | ||
| 24-04-17 | Other | Chairman | 240,000 | 0.0320% | ||
| 24-04-17 | Other | Chairman | 240,000 | 0.0320% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.90% | -2.02% | +145.57% | -23.02% | 96.18M | |
| -0.62% | +1.33% | +11.56% | +87.23% | 47.37B | |
| +0.51% | +3.61% | +53.47% | +102.47% | 35.31B | |
| +0.15% | +6.53% | -4.87% | +40.92% | 12.33B | |
| +0.19% | +2.86% | +12.16% | +96.05% | 11.64B | |
| -0.57% | +0.38% | +37.08% | +123.40% | 9.04B | |
| +0.99% | +4.52% | +21.63% | +46.21% | 7.12B | |
| +1.58% | +5.71% | +54.89% | -11.94% | 6.8B | |
| -1.20% | -2.67% | +24.39% | +233.81% | 6.44B | |
| -3.83% | -0.76% | -34.46% | -1.98% | 5.14B | |
| Average | -0.77% | +1.96% | +32.14% | +69.32% | 14.13B | |
| Weighted average by Cap. | -0.16% | +1.79% | +23.88% | +86.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 326M 376M 47.93M 42.02M 38.74M 36.26M 68M 4.52B 69.41M 466M 180M 2.23B 180M 176M 7.75B | 273M 315M 40.19M 35.24M 32.48M 30.41M 57.02M 3.79B 58.2M 390M 151M 1.87B 151M 148M 6.5B |
| Net income | -189M -218M -27.75M -24.33M -22.43M -21M -39.38M -2.62B -40.19M -270M -104M -1.29B -104M -102M -4.49B | -11.78M -13.58M -1.73M -1.52M -1.4M -1.31M -2.46M -163M -2.51M -16.83M -6.51M -80.76M -6.5M -6.36M -280M |
| Net Debt | 367M 423M 53.99M 47.34M 43.63M 40.85M 76.6M 5.09B 78.19M 524M 203M 2.52B 203M 198M 8.73B | 222M 256M 32.63M 28.61M 26.38M 24.69M 46.3M 3.08B 47.26M 317M 123M 1.52B 123M 120M 5.28B |
Employees
1,005
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-26 | HK$0.9700 | -4.90% | 235,000 |
| 26-06-25 | HK$1.020 | -4.67% | 108,000 |
| 26-06-24 | HK$1.070 | -1.83% | 55,000 |
| 26-06-23 | HK$1.090 | +1.87% | 231,000 |
| 26-06-22 | HK$1.070 | +8.08% | 311,000 |
- Stock Market
- Stocks
- 1652 Stock
Select your edition
All financial news and data tailored to specific country editions
